---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-045305"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T12:42:17.684142+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics raises $15M in private placement; exchanges $3.2M in convertible notes

## Summary
- Private placement of ~28M shares (or prefunded warrants) at $0.66/unit, each with Series A and B warrants.
- Gross proceeds of ~$15M; includes exchange of $3.2M convertible notes for securities in the placement.
- Company repurchases $3.4M in notes and 3M warrants for $4.25M, eliminating financing restrictions.
- Believes it has regained compliance with Nasdaq minimum stockholders' equity requirement (Rule 5550(b)(1)).
- Closing contingent on Nasdaq confirmation by March 31, 2025; funds held in escrow pending.

## SEC filing metadata
- accession: 0001193125-25-045305
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312525045305/0001193125-25-045305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312525045305/d875007d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-045305
- JSON: https://secwatch.observer/filing/0001193125-25-045305.json
- Plain text: https://secwatch.observer/filing/0001193125-25-045305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.